{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T19:47:15Z","timestamp":1781725635429,"version":"3.54.5"},"reference-count":69,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"name":"Fogarty International Center and National Institutes of Mental Health","award":["R21 MH102374-01"],"award-info":[{"award-number":["R21 MH102374-01"]}]},{"DOI":"10.13039\/501100003141","name":"Consejo Nacional de Ciencia y Tecnolog\u00eda","doi-asserted-by":"publisher","award":["261895"],"award-info":[{"award-number":["261895"]}],"id":[{"id":"10.13039\/501100003141","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003141","name":"CONACYT","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003141","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009670","name":"NARSAD","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009670","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Schizophrenia Research"],"published-print":{"date-parts":[[2020,12]]},"DOI":"10.1016\/j.schres.2020.01.003","type":"journal-article","created":{"date-parts":[[2020,2,21]],"date-time":"2020-02-21T04:10:14Z","timestamp":1582258214000},"page":"13-23","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":25,"special_numbering":"C","title":["Immuno-inflammatory changes across phases of early psychosis: The impact of antipsychotic medication and stage of illness"],"prefix":"10.1016","volume":"226","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5952-4605","authenticated-orcid":false,"given":"Skylar","family":"Kelsven","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0773-1642","authenticated-orcid":false,"given":"Camilo","family":"de la Fuente-Sandoval","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristian L.","family":"Achim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0772-4119","authenticated-orcid":false,"given":"Francisco","family":"Reyes-Madrigal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heline","family":"Mirzakhanian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabel","family":"Domingues","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristin","family":"Cadenhead","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.schres.2020.01.003_bb0005","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1016\/S2215-0366(15)00544-1","article-title":"Childhood maltreatment and unfavorable clinical outcomes in bipolar disorder: a systematic review and meta-analysis","volume":"3","author":"Agnew-Blais","year":"2016","journal-title":"Lancet Psychiatry"},{"key":"10.1016\/j.schres.2020.01.003_bb0015","series-title":"Diagnostic and Statistical Manual of Mental Disorders","author":"APA","year":"1994"},{"key":"10.1016\/j.schres.2020.01.003_bb0020","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.eurpsy.2016.05.010","article-title":"Inflammatory, cardio-metabolic and diabetic profiling of chronic schizophrenia","volume":"39","author":"Bal\u00f5t\u0161ev","year":"2017","journal-title":"Eur Psychiatry"},{"issue":"10","key":"10.1016\/j.schres.2020.01.003_bb0025","doi-asserted-by":"crossref","first-page":"2384","DOI":"10.2337\/diabetes.50.10.2384","article-title":"The relation of markers of inflammation to the development of glucose disorders in the elderly: the cardiovascular health study","volume":"50","author":"Barzilay","year":"2001","journal-title":"Diabetes"},{"issue":"9","key":"10.1016\/j.schres.2020.01.003_bb0030","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1007\/s00213-015-4044-5","article-title":"Effects of psychotropic drugs on inflammation: consequence or mediator of therapeutic effects in psychiatric treatment?","volume":"233","author":"Baumeister","year":"2016","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.schres.2020.01.003_bb0045","doi-asserted-by":"crossref","first-page":"14","DOI":"10.3389\/neuro.08.014.2009","article-title":"Early-life programming of later-life brain and behavior: a critical role for the immune system","volume":"3","author":"Bilbo","year":"2009","journal-title":"Front. Behav. Neurosci."},{"issue":"3","key":"10.1016\/j.schres.2020.01.003_bb0050","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.bbi.2009.09.012","article-title":"Enduring consequences of early-life infection on glial and neural cell genesis within cognitive regions of the brain","volume":"24","author":"Bland","year":"2010","journal-title":"Brain Behav. Immun."},{"issue":"2","key":"10.1016\/j.schres.2020.01.003_bb0055","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.pneurobio.2005.06.004","article-title":"Microglia and inflammation-mediated neurodegeneration: multiple triggers with a common mechanism","volume":"76","author":"Block","year":"2005","journal-title":"Prog. Neurobiol."},{"issue":"1","key":"10.1016\/j.schres.2020.01.003_bb0060","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1176\/appi.ajp.2015.14101358","article-title":"Microglial activity in people at ultra high risk of psychosis and in schizophrenia: an [(11)C]PBR28 PET brain imaging study","volume":"173","author":"Bloomfield","year":"2016","journal-title":"Am. J. Psychiatry"},{"issue":"1","key":"10.1016\/j.schres.2020.01.003_bb0065","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.schres.2013.03.027","article-title":"Antipsychotics can modulate the cytokine profile in schizophrenia: attenuation of the type-2 inflammatory response","volume":"147","author":"Borovcanin","year":"2013","journal-title":"Schizophr. Res."},{"issue":"2","key":"10.1016\/j.schres.2020.01.003_bb0075","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1097\/QAD.0000000000001687","article-title":"Sex-based differences in neurocognitive functioning in HIV-infected young adults","volume":"32","author":"Burlacu","year":"2018","journal-title":"AIDS"},{"key":"10.1016\/j.schres.2020.01.003_bb0080","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.schres.2018.09.022","article-title":"Metabolic abnormalities and low dietary Omega 3 are associated with symptom severity and worse functioning prior to the onset of psychosis: findings from the North American Prodrome Longitudinal Studies Consortium","volume":"204","author":"Cadenhead","year":"2019","journal-title":"Schizophr. Res."},{"issue":"10","key":"10.1016\/j.schres.2020.01.003_bb0085","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1176\/appi.ajp.2016.15070890","article-title":"An individualized risk calculator for research in prodromal psychosis","volume":"173","author":"Cannon","year":"2016","journal-title":"Am. J. Psychiatry"},{"issue":"12","key":"10.1016\/j.schres.2020.01.003_bb0090","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1097\/NMD.0000000000000049","article-title":"The role of early life stress in adult psychiatric disorders: a systematic review according to childhood trauma subtypes","volume":"201","author":"Carr","year":"2013","journal-title":"J. Nerv. Ment. Dis."},{"key":"10.1016\/j.schres.2020.01.003_bb0095","doi-asserted-by":"crossref","first-page":"e601","DOI":"10.1038\/tp.2015.91","article-title":"Development of a blood-based molecular biomarker test for identification of schizophrenia before disease onset","volume":"5","author":"Chan","year":"2015","journal-title":"Transl. Psychiatry"},{"issue":"12","key":"10.1016\/j.schres.2020.01.003_bb0105","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1001\/jamapsychiatry.2014.1314","article-title":"Cardiometabolic risk in patients with first-episode schizophrenia spectrum disorders: baseline results from the RAISE-ETP study","volume":"71","author":"Correll","year":"2014","journal-title":"JAMA Psychiatry"},{"key":"10.1016\/j.schres.2020.01.003_bb0115","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1146\/annurev-psych-010416-044208","article-title":"Hidden wounds? Inflammatory links between childhood trauma and psychopathology","volume":"68","author":"Danese","year":"2017","journal-title":"Annu. Rev. Psychol."},{"issue":"2","key":"10.1016\/j.schres.2020.01.003_bb0125","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1007\/s11906-010-0095-5","article-title":"Cytokine abnormalities in the etiology of the cardiometabolic syndrome","volume":"12","author":"DeMarco","year":"2010","journal-title":"Curr. Hypertens. Rep."},{"issue":"2","key":"10.1016\/j.schres.2020.01.003_bb0130","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0009166","article-title":"Plasma protein biomarkers for depression and schizophrenia by multi analyte profiling of case-control collections","volume":"5","author":"Domenici","year":"2010","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.schres.2020.01.003_bb0135","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1186\/2194-7511-2-4","article-title":"Immunological and neurotrophic markers of risk status and illness development in high-risk youth: understanding the neurobiological underpinnings of bipolar disorder","volume":"2","author":"Duffy","year":"2014","journal-title":"Int J Bipolar Disord"},{"issue":"1","key":"10.1016\/j.schres.2020.01.003_bb0140","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1186\/s12888-016-1039-7","article-title":"Differential expression of the inflammation marker IL12p40 in the at-risk mental state for psychosis: a predictor of transition to psychotic disorder?","volume":"16","author":"Focking","year":"2016","journal-title":"BMC Psychiatry"},{"issue":"3","key":"10.1016\/j.schres.2020.01.003_bb0145","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1192\/bjp.200.3.254a","article-title":"Predicting the development of schizophrenia","volume":"200","author":"Fusar-Poli","year":"2012","journal-title":"Br. J. Psychiatry"},{"issue":"12","key":"10.1016\/j.schres.2020.01.003_bb0150","doi-asserted-by":"crossref","first-page":"1763","DOI":"10.1016\/j.neurobiolaging.2005.10.007","article-title":"Serum MCP-1 levels are increased in mild cognitive impairment and mild Alzheimer\u2019s disease","volume":"27","author":"Galimberti","year":"2006","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.schres.2020.01.003_bb0155","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/j.bbi.2018.11.315","article-title":"Association of baseline inflammatory markers and the development of negative symptoms in individuals at clinical high risk for psychosis","volume":"76","author":"Goldsmith","year":"2019","journal-title":"Brain Behav. Immun."},{"issue":"9","key":"10.1016\/j.schres.2020.01.003_bb0160","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1038\/mp.2010.88","article-title":"Brain-derived neurotrophic factor levels in schizophrenia: a systematic review with meta-analysis","volume":"16","author":"Green","year":"2011","journal-title":"Mol. Psychiatry"},{"issue":"1\u20133","key":"10.1016\/j.schres.2020.01.003_bb0170","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.schres.2015.08.027","article-title":"Antipsychotic treatment reduces psychotic symptoms and markers of low-grade inflammation in first episode psychosis patients, but increases their body mass index","volume":"169","author":"Haring","year":"2015","journal-title":"Schizophr. Res."},{"issue":"5","key":"10.1016\/j.schres.2020.01.003_bb0175","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1001\/jama.284.5.592","article-title":"Pituitary-adrenal and autonomic responses to stress in women after sexual and physical abuse in childhood","volume":"284","author":"Heim","year":"2000","journal-title":"JAMA"},{"issue":"4","key":"10.1016\/j.schres.2020.01.003_bb0180","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1176\/appi.ajp.158.4.575","article-title":"Altered pituitary-adrenal axis responses to provocative challenge tests in adult survivors of childhood abuse","volume":"158","author":"Heim","year":"2001","journal-title":"Am. J. Psychiatry"},{"issue":"3","key":"10.1016\/j.schres.2020.01.003_bb0185","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1002\/da.10015","article-title":"The role of early adverse experience and adulthood stress in the prediction of neuroendocrine stress reactivity in women: a multiple regression analysis","volume":"15","author":"Heim","year":"2002","journal-title":"Depress Anxiety"},{"issue":"6","key":"10.1016\/j.schres.2020.01.003_bb0190","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1016\/j.psyneuen.2008.03.008","article-title":"The link between childhood trauma and depression: insights from HPA axis studies in humans","volume":"33","author":"Heim","year":"2008","journal-title":"Psychoneuroendocrinology"},{"issue":"7","key":"10.1016\/j.schres.2020.01.003_bb0195","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1002\/dev.20494","article-title":"Neurobiological and psychiatric consequences of child abuse and neglect","volume":"52","author":"Heim","year":"2010","journal-title":"Dev. Psychobiol."},{"key":"10.1016\/j.schres.2020.01.003_bb0200","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.schres.2016.09.019","article-title":"Abnormalities in chemokine levels in schizophrenia and their clinical correlates","volume":"181","author":"Hong","year":"2017","journal-title":"Schizophr. Res."},{"issue":"1\u20132","key":"10.1016\/j.schres.2020.01.003_bb0205","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.addbeh.2010.09.001","article-title":"The long-term effects of childhood maltreatment experiences on subsequent illicit drug use and drug-related problems in young adulthood","volume":"36","author":"Huang","year":"2011","journal-title":"Addict. Behav."},{"issue":"10","key":"10.1016\/j.schres.2020.01.003_bb0210","doi-asserted-by":"crossref","DOI":"10.3390\/ijms18102174","article-title":"Unresolved issues for utilization of atypical antipsychotics in schizophrenia: antipsychotic polypharmacy and metabolic syndrome","volume":"18","author":"Jeon","year":"2017","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.schres.2020.01.003_bb0215","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.schres.2018.06.039","article-title":"Comparison of the anti-inflammatory effect of aripiprazole and risperidone in 75 drug-na\u00efve first episode psychosis individuals: a 3 months randomized study","volume":"202","author":"Juncal-Ruiz","year":"2018","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.schres.2020.01.003_bb0220","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.ajp.2017.01.026","article-title":"Cytokines, cortisol and IGF-1 in first episode psychosis and ultra high risk males. Evidence for TNF-\u03b1, IFN-\u03b3, \u03a4NF-\u03b2, IL-4 deviation","volume":"26","author":"Karanikas","year":"2017","journal-title":"Asian J. Psychiatr."},{"issue":"2","key":"10.1016\/j.schres.2020.01.003_bb0225","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1093\/schbul\/13.2.261","article-title":"The positive and negative syndrome scale (PANSS) for schizophrenia","volume":"13","author":"Kay","year":"1987","journal-title":"Schizophr. Bull."},{"issue":"1","key":"10.1016\/j.schres.2020.01.003_bb0240","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.jagp.2016.09.009","article-title":"Inflammation in schizophrenia: cytokine levels and their relationships to demographic and clinical variables","volume":"25","author":"Lee","year":"2017","journal-title":"Am. J. Geriatr. Psychiatry"},{"issue":"5 Suppl","key":"10.1016\/j.schres.2020.01.003_bb0245","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1177\/0269881111431622","article-title":"The metabolic syndrome in schizophrenia: is inflammation a contributing cause?","volume":"26","author":"Leonard","year":"2012","journal-title":"J. Psychopharmacol."},{"issue":"6","key":"10.1016\/j.schres.2020.01.003_bb0250","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1038\/nrn2639","article-title":"Effects of stress throughout the lifespan on the brain, behaviour and cognition","volume":"10","author":"Lupien","year":"2009","journal-title":"Nat. Rev. Neurosci."},{"issue":"1","key":"10.1016\/j.schres.2020.01.003_bb0255","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1017\/S1461145711001775","article-title":"Risperidone normalizes increased inflammatory parameters and restores anti-inflammatory pathways in a model of neuroinflammation","volume":"16","author":"MacDowell","year":"2013","journal-title":"Int. J. Neuropsychopharmacol."},{"issue":"6","key":"10.1016\/j.schres.2020.01.003_bb0260","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1016\/j.eurpsy.2015.04.007","article-title":"The role of specific early trauma in adult depression: a meta-analysis of published literature. Childhood trauma and adult depression","volume":"30","author":"Mandelli","year":"2015","journal-title":"Eur Psychiatry"},{"issue":"1\u20133","key":"10.1016\/j.schres.2020.01.003_bb0265","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.schres.2012.03.004","article-title":"Cognitive impairment is related to oxidative stress and chemokine levels in first psychotic episodes","volume":"137","author":"Mart\u00ednez-Cengotitabengoa","year":"2012","journal-title":"Schizophr. Res."},{"issue":"3","key":"10.1016\/j.schres.2020.01.003_bb0270","doi-asserted-by":"crossref","first-page":"853","DOI":"10.3233\/JAD-160488","article-title":"Inflammation, antiinflammatory agents, and Alzheimer\u2019s disease: the last 22 years","volume":"54","author":"McGeer","year":"2016","journal-title":"J. Alzheimers Dis."},{"issue":"6","key":"10.1016\/j.schres.2020.01.003_bb0290","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1016\/j.neubiorev.2004.10.012","article-title":"Towards an immuno-precipitated neurodevelopmental animal model of schizophrenia","volume":"29","author":"Meyer","year":"2005","journal-title":"Neurosci. Biobehav. Rev."},{"issue":"4","key":"10.1016\/j.schres.2020.01.003_bb0295","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1023\/A:1022034115078","article-title":"Symptom assessment in schizophrenic prodromal states","volume":"70","author":"Miller","year":"1999","journal-title":"Psychiatr Q"},{"issue":"5","key":"10.1016\/j.schres.2020.01.003_bb0300","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1093\/schbul\/sbv028","article-title":"Cortisol and inflammatory biomarkers predict poor treatment response in first episode psychosis","volume":"41","author":"Mondelli","year":"2015","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.schres.2020.01.003_bb0305","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.pnpbp.2011.12.002","article-title":"Neuroinflammation in schizophrenia especially focused on the role of microglia","volume":"42","author":"Monji","year":"2013","journal-title":"Prog. Neuro-Psychopharmacol. Biol. Psychiatry"},{"issue":"1\u20132","key":"10.1016\/j.schres.2020.01.003_bb0310","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.jneuroim.2005.07.012","article-title":"Dynamics of monocyte chemoattractant protein type one (MCP-1) and HIV viral load in human cerebrospinal fluid and plasma","volume":"169","author":"Monteiro de Almeida","year":"2005","journal-title":"J. Neuroimmunol."},{"issue":"Suppl. 1","key":"10.1016\/j.schres.2020.01.003_bb0315","first-page":"18","article-title":"Neurobiological consequences of childhood trauma","volume":"65","author":"Nemeroff","year":"2004","journal-title":"J Clin Psychiatry"},{"issue":"4","key":"10.1016\/j.schres.2020.01.003_bb0320","doi-asserted-by":"crossref","DOI":"10.1093\/ijnp\/pyu042","article-title":"Effects of risperidone on cytokine profile in drug-na\u00efve first-episode psychosis","volume":"18","author":"Noto","year":"2014","journal-title":"Int. J. Neuropsychopharmacol."},{"issue":"2","key":"10.1016\/j.schres.2020.01.003_bb0330","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1093\/schbul\/sbu099","article-title":"Towards a psychosis risk blood diagnostic for persons experiencing high-risk symptoms: preliminary results from the NAPLS project","volume":"41","author":"Perkins","year":"2015","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.schres.2020.01.003_bb0335","series-title":"Neurobiological Sequelae of Childhood Trauma: Post-traumatic Stress Disorders in Children Catecholamine Function in Post Traumatic Stress Disorder: Emerging Concepts","first-page":"253","author":"Perry","year":"1994"},{"key":"10.1016\/j.schres.2020.01.003_bb0350","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1186\/1471-244X-13-27","article-title":"Plasma brain-derived neurotrophic factor levels, learning capacity and cognition in patients with first episode psychosis","volume":"13","author":"Ruiz de Azua","year":"2013","journal-title":"BMC Psychiatry"},{"key":"10.1016\/j.schres.2020.01.003_bb0355","doi-asserted-by":"crossref","first-page":"203","DOI":"10.3389\/fpsyt.2017.00203","article-title":"Inflammation, stress response, and redox dysregulation biomarkers: clinical outcomes and pharmacological implications for psychosis","volume":"8","author":"Schiavone","year":"2017","journal-title":"Front Psychiatry"},{"issue":"8","key":"10.1016\/j.schres.2020.01.003_bb0360","doi-asserted-by":"crossref","first-page":"627","DOI":"10.3109\/15622975.2011.599861","article-title":"Identification of a blood-based biological signature in subjects with psychiatric disorders prior to clinical manifestation","volume":"13","author":"Schwarz","year":"2012","journal-title":"World J Biol Psychiatry"},{"issue":"4","key":"10.1016\/j.schres.2020.01.003_bb0365","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1093\/schbul\/sbt105","article-title":"Identification of subgroups of schizophrenia patients with changes in either immune or growth factor and hormonal pathways","volume":"40","author":"Schwarz","year":"2014","journal-title":"Schizophr. Bull."},{"issue":"5","key":"10.1016\/j.schres.2020.01.003_bb0375","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1097\/JCP.0000000000000378","article-title":"Lower brain-derived neurotropic factor levels in untreated adolescents with first-episode psychosis","volume":"35","author":"Simsek","year":"2015","journal-title":"J. Clin. Psychopharmacol."},{"issue":"2","key":"10.1016\/j.schres.2020.01.003_bb0385","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1007\/s00213-013-3382-4","article-title":"Changes in pro-inflammatory cytokines and body weight during 6-month risperidone treatment in drug na\u00efve, first-episode schizophrenia","volume":"231","author":"Song","year":"2014","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.schres.2020.01.003_bb0390","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.psyneuen.2013.12.005","article-title":"Increased serum interleukin-6 levels in early stages of psychosis: associations with at-risk mental states and the severity of psychotic symptoms","volume":"41","author":"Stojanovic","year":"2014","journal-title":"Psychoneuroendocrinology"},{"issue":"2","key":"10.1016\/j.schres.2020.01.003_bb0395","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.pnpbp.2008.12.006","article-title":"Atypical antipsychotics suppress production of proinflammatory cytokines and up-regulate interleukin-10 in lipopolysaccharide-treated mice","volume":"33","author":"Sugino","year":"2009","journal-title":"Prog. Neuro-Psychopharmacol. Biol. Psychiatry"},{"issue":"1","key":"10.1016\/j.schres.2020.01.003_bb0400","doi-asserted-by":"crossref","first-page":"154","DOI":"10.5498\/wjp.v5.i1.154","article-title":"Brain-derived neurotrophic factor levels in first episode of psychosis: a systematic review","volume":"5","author":"Toll","year":"2015","journal-title":"World J Psychiatry"},{"issue":"1\u20133","key":"10.1016\/j.schres.2020.01.003_bb0405","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.schres.2013.10.011","article-title":"Antipsychotics\u2019 effects on blood levels of cytokines in schizophrenia: a meta-analysis","volume":"151","author":"Tourjman","year":"2013","journal-title":"Schizophr. Res."},{"issue":"4","key":"10.1016\/j.schres.2020.01.003_bb0410","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1016\/S0022-3999(02)00429-4","article-title":"Hypothalamic-pituitary-adrenal axis, neuroendocrine factors and stress","volume":"53","author":"Tsigos","year":"2002","journal-title":"J. Psychosom. Res."},{"issue":"6","key":"10.1016\/j.schres.2020.01.003_bb0430","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1038\/s41591-018-0021-y","article-title":"Convergence of placenta biology and genetic risk for schizophrenia","volume":"24","author":"Ursini","year":"2018","journal-title":"Nat. Med."},{"issue":"4","key":"10.1016\/j.schres.2020.01.003_bb0440","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1093\/schbul\/sbs050","article-title":"Childhood adversities increase the risk of psychosis: a meta-analysis of patient-control, prospective- and cross-sectional cohort studies","volume":"38","author":"Varese","year":"2012","journal-title":"Schizophr. Bull."},{"issue":"8","key":"10.1016\/j.schres.2020.01.003_bb0445","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1093\/ijnp\/pyy036","article-title":"Levels of serum brain-derived neurotropic factor in individuals at ultra-high risk for psychosis - findings from the longitudinal youth at risk study (LYRIKS)","volume":"21","author":"Yee","year":"2018","journal-title":"Int. J. Neuropsychopharmacol."},{"issue":"1","key":"10.1016\/j.schres.2020.01.003_bb0450","first-page":"21","article-title":"Metabolic complications of schizophrenia and antipsychotic medications\u2014an updated review","volume":"23","author":"Yogaratnam","year":"2013","journal-title":"East Asian Arch Psychiatry"},{"issue":"2-3","key":"10.1016\/j.schres.2020.01.003_bb2010","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.schres.2016.06.031","article-title":"Peripheral immuno-inflammatory abnormalities in ultra-high risk of developing psychosis","volume":"176","author":"Zeni-Graiff","year":"2016","journal-title":"Schizophr. Res."}],"container-title":["Schizophrenia Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0920996420300190?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0920996420300190?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T19:40:35Z","timestamp":1760298035000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0920996420300190"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,12]]},"references-count":69,"alternative-id":["S0920996420300190"],"URL":"https:\/\/doi.org\/10.1016\/j.schres.2020.01.003","relation":{},"ISSN":["0920-9964"],"issn-type":[{"value":"0920-9964","type":"print"}],"subject":[],"published":{"date-parts":[[2020,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Immuno-inflammatory changes across phases of early psychosis: The impact of antipsychotic medication and stage of illness","name":"articletitle","label":"Article Title"},{"value":"Schizophrenia Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.schres.2020.01.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}